Jade Biosciences is focused on developing innovative, best-in-class therapies to address critical unmet needs in autoimmune diseases. Our lead candidate, JADE101, is designed to inhibit the cytokine APRIL (A Proliferation-Inducing Ligand) and is being developed for the treatment of immunoglobulin A nephropathy (IgAN), a chronic kidney disease that can impair kidney function over time. JADE101 aims to reduce harmful IgA antibodies, lower proteinuria (a key marker of kidney damage), and preserve long-term kidney function. A Phase 1 healthy-volunteer study of JADE101 is ongoing, with interim, biomarker-rich data expected in the first half of 2026. Jade’s pipeline also includes a second development candidate, JADE201, and an undisclosed antibody discovery program, JADE-003, both currently in preclinical development. For more information, visit JadeBiosciences.com and follow us on LinkedIn. The Associate Director, Biosample Operations will oversee all aspects of biosample management strategy, governance, and logistics for Jade’s clinical trial programs. This individual will serve as the bridge between Clinical Operations, Research & Translational Medicine and external partners to ensure high-quality sample collection, processing, tracking, and analysis. The ideal candidate is both strategic and execution-focused, with deep operational expertise and the ability to thrive in a small, dynamic environment. This is an exciting opportunity to make important contributions at Jade by leading and implementing crucial biosample strategies.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
11-50 employees